Protein analysis in cerebrospinal fluid samples
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00382
- Awardee
-
Amprion, Inc. UEI QBCELFPYPNJ3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,126,400
Award facts
- Opportunity
-
- SOURCES SOUGHT: Protein Analysis in Cerebrospinal Fluid Samples (CSF) Pre-Solicitation · 75N95024Q00278 · Posted May 8, 2024
- Contract value 63% obligated
-
- $1,126,400.00 Current, with exercised options
- $1,786,400.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94105, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $246,400 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $352,000 | |
| Original award | $528,000 |
About this award
This $1,786,400.00 firm fixed price purchase order contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit company specializing in neurological diagnostic services. The contract is for protein analysis services focused on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing Amprion's proprietary SYNTap assay technology. The contract has a period of performance from August 1, 2024 to September 30, 2025 and was not set aside for any specific business size or type. This award is part of the NIA's work to advance diagnostic methodologies for understanding complex neurological conditions like Alzheimer's Disease, Parkinson's Disease, and Related Dementias.
Quick answers
Who was awarded contract 75N95024P00382?
75N95024P00382 was awarded to Amprion, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024P00382 worth?
The government has obligated $1,126,400 on 75N95024P00382. Its potential value, with all options, is $1,786,400.
Which agency awarded contract 75N95024P00382?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00382, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95024P00382 competed?
The extent of competition for 75N95024P00382 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award